COLL Operating Cash Flow (Statement)
Collegium Pharmaceutical Inc · Operating Cash Flow (Statement)
COLL Operating Cash Flow (Statement)
Latest reported$329.92Mperiod ending
COLL TTM Cash from Operations (-$17.95M → $329.92M)
TTM operating cash flow (statement)
High-resolution chart · PNG
COLL operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 329,922,000 | |
| 331,038,000 | |
| 329,323,000 | |
| 290,919,000 | |
| 203,482,000 | |
| 198,441,000 | |
| 204,980,000 | |
| 193,674,000 | |
| 276,691,000 | |
| 309,015,000 | |
| 274,749,000 | |
| 267,736,000 | |
| 236,487,000 | |
| 177,216,000 | |
| 124,230,000 | |
| 94,103,000 | |
| 68,588,000 | |
| 57,672,000 | |
| 103,557,000 | |
| 89,936,000 | |
| 106,862,000 | |
| 121,181,000 | |
| 93,942,000 | |
| 87,021,000 | |
| 58,910,000 | |
| 29,683,000 | |
| 27,783,000 | |
| 54,415,000 | |
| 90,180,000 | |
| 131,158,000 | |
| 169,390,000 | |
| 113,806,000 | |
| 59,405,000 | |
| -13,667,000 | |
| -67,018,000 | |
| -77,009,000 | |
| -83,856,000 | |
| -87,225,000 | |
| -75,053,000 | |
| -60,705,000 | |
| -47,827,000 | |
| -31,402,000 | |
| -21,567,000 | |
| -20,195,000 | |
| -18,067,000 | |
| -15,857,000 | |
| -17,947,000 |